| Bioactivity | ATWLPPR Peptide is a biological active peptide. (This peptide is a specific VEGFR2/KDR heptapeptide antagonist, it binds VEGFR2 (KDR/flk), completely inhibiting VEGF binding to KDR and preventing VEGF-induced angiogenesis in-vivo. It specifically inhibits human endothelial cell proliferation in-vitro and totally abolishes VEGF-induced angiogenesis in-vivo.) |
| Name | ATWLPPR Peptide |
| CAS | 272121-15-0 |
| Sequence | Ala-Thr-Trp-Leu-Pro-Pro-Arg |
| Shortening | ATWLPPR |
| Formula | C40H61N11O9 |
| Molar Mass | 839.98 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
ATWLPPR Peptide
CAS: 272121-15-0 F: C40H61N11O9 W: 839.98
ATWLPPR Peptide is a biological active peptide. (This peptide is a specific VEGFR2/KDR heptapeptide antagonist, it binds
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.